178 related articles for article (PubMed ID: 32381297)
21. Immune Priming of the Tumor Microenvironment by Radiation.
Jiang W; Chan CK; Weissman IL; Kim BYS; Hahn SM
Trends Cancer; 2016 Nov; 2(11):638-645. PubMed ID: 28741502
[TBL] [Abstract][Full Text] [Related]
22. The effect of radiation on the immune response to cancers.
Park B; Yee C; Lee KM
Int J Mol Sci; 2014 Jan; 15(1):927-43. PubMed ID: 24434638
[TBL] [Abstract][Full Text] [Related]
23. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
Han X; Li H; Zhou D; Chen Z; Gu Z
Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
[TBL] [Abstract][Full Text] [Related]
24. In vivo effects of lattice radiation therapy on local and distant lung cancer: potential role of immunomodulation.
Kanagavelu S; Gupta S; Wu X; Philip S; Wattenberg MM; Hodge JW; Couto MD; Chung KD; Ahmed MM
Radiat Res; 2014 Aug; 182(2):149-62. PubMed ID: 25036982
[TBL] [Abstract][Full Text] [Related]
25. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
26. The Effects of Radiation Dose Heterogeneity on the Tumor Microenvironment and Anti-Tumor Immunity.
Takashima ME; Berg TJ; Morris ZS
Semin Radiat Oncol; 2024 Jul; 34(3):262-271. PubMed ID: 38880534
[TBL] [Abstract][Full Text] [Related]
27. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
28. Radiation-Induced Transformation of Immunoregulatory Networks in the Tumor Stroma.
Martinez-Zubiaurre I; Chalmers AJ; Hellevik T
Front Immunol; 2018; 9():1679. PubMed ID: 30105016
[TBL] [Abstract][Full Text] [Related]
29. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
Darragh LB; Oweida AJ; Karam SD
Front Immunol; 2018; 9():3154. PubMed ID: 30766539
[TBL] [Abstract][Full Text] [Related]
30. Amplified Cancer Immunotherapy of a Surface-Engineered Antigenic Microparticle Vaccine by Synergistically Modulating Tumor Microenvironment.
Zhao H; Zhao B; Wu L; Xiao H; Ding K; Zheng C; Song Q; Sun L; Wang L; Zhang Z
ACS Nano; 2019 Nov; 13(11):12553-12566. PubMed ID: 31689085
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation.
Hoopes PJ; Wagner RJ; Duval K; Kang K; Gladstone DJ; Moodie KL; Crary-Burney M; Ariaspulido H; Veliz FA; Steinmetz NF; Fiering SN
Mol Pharm; 2018 Sep; 15(9):3717-3722. PubMed ID: 29613803
[TBL] [Abstract][Full Text] [Related]
32. At the bench: Engineering the next generation of cancer vaccines.
Shae D; Baljon JJ; Wehbe M; Becker KW; Sheehy TL; Wilson JT
J Leukoc Biol; 2020 Oct; 108(4):1435-1453. PubMed ID: 31430398
[TBL] [Abstract][Full Text] [Related]
33. Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.
Frey B; Rubner Y; Wunderlich R; Weiss EM; Pockley AG; Fietkau R; Gaipl US
Curr Med Chem; 2012; 19(12):1751-64. PubMed ID: 22414083
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.
Frey B; Rückert M; Deloch L; Rühle PF; Derer A; Fietkau R; Gaipl US
Immunol Rev; 2017 Nov; 280(1):231-248. PubMed ID: 29027224
[TBL] [Abstract][Full Text] [Related]
35.
Zhang Y; Rahman MM; Clark PA; Sriramaneni RN; Havighurst T; Kerr CP; Zhu M; Jones J; Wang X; Kim K; Gong S; Morris ZS
ACS Nano; 2023 Jun; 17(11):10236-10251. PubMed ID: 37216491
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
[TBL] [Abstract][Full Text] [Related]
37. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Demaria S; Guha C; Schoenfeld J; Morris Z; Monjazeb A; Sikora A; Crittenden M; Shiao S; Khleif S; Gupta S; Formenti SC; Vikram B; Coleman CN; Ahmed MM
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33827904
[TBL] [Abstract][Full Text] [Related]
38. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
Sheen MR; Fiering S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
[TBL] [Abstract][Full Text] [Related]
39. Combining
Kalami A; Shahgolzari M; Khosroushahi AY; Fiering S
Immunotherapy; 2023 Apr; 15(5):367-381. PubMed ID: 36852419
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
Lee L; Matulonis U
Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
